Ali health (00241) announced that the board of directors of the company received a notice from innovare tech Limited (innovare, a shareholder of the company, holds a total of 932 million shares of the company, accounting for about 6.90% of the issued share capital of the company on the date of this announcement). On May 20, 2022, innovare has distributed some of its shares (i.e. 641 million shares) (distribution shares) to Yunfeng Fund II, the beneficial owner of all its voting share capital, 50. The quota proportion of each limited partner of P. in innovare is distributed to such equity holders in kind. Immediately after the distribution, the equity holders who receive the distribution shares in the distribution will become the direct shareholders of the company.
As far as the directors know, know and believe after making all reasonable inquiries, 487165 million distributed shares have been distributed to Alibaba Investment Limited Alibaba Investment Limited is a wholly-owned subsidiary of Alibaba Group Holdings Limited (Alibaba Holdings), and Alibaba holdings is the ultimate shareholder of perfect advance holding limited. The distribution will increase the number of shares indirectly held by Alibaba holdings from 7.665 billion shares to 7.713 billion shares, accounting for about 56.70% of the total issued share capital of the company to about 57.06%.
After the distribution, Alibaba Holdings (through its subsidiaries) remains the largest and ultimate controlling shareholder of the company.
